<DOC>
	<DOCNO>NCT00134914</DOCNO>
	<brief_summary>Buprenorphine treatment opioid dependence . Naloxone give addition buprenorphine order limit abuse potential commonly associate buprenorphine . The purpose study examine effect buprenorphine/naloxone give different route different dos .</brief_summary>
	<brief_title>Effects Buprenorphine/Naloxone Administered Different Ways For Treating Opioid Dependence</brief_title>
	<detailed_description>Buprenorphine , mixed agonist-antagonist opioid ( partial agonist ) , safe effective treatment opioid dependence . However , concern buprenorphine may abuse due high abuse potential . A sublingual buprenorphine/naloxone combination tablet may reduce risk abuse associate buprenorphine alone . The purpose study characterize effect buprenorphine/naloxone opioid-dependent individual . This study last 10 week . Participants stay residential research unit , maintain oral hydromorphone ( 10 mg ) . During twice-weekly experimental session , participant randomly assign receive either sublingual tablet , intramuscular injection , placebo . The 15 condition study include : sublingual intramuscular buprenorphine/naloxone ( 1/0.25 mg , 2/0.5 mg , 4/1 mg , 8/2 mg , 16/4 mg ) , 0.25 mg intramuscular naloxone ( antagonist control ) , 10 mg intramuscular hydromorphone ( agonist control ) , sublingual intramuscular buprenorphine ( 8 mg ) , placebo .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>Currently opioid dependent In good health , determine preparticipation medical examination Seeking eligible methadone maintenance detoxification treatment Significant medical psychiatric illness , drug dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>opiate dependence</keyword>
</DOC>